Your browser doesn't support javascript.
loading
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
Hertz, Daniel L; Owzar, Kouros; Lessans, Sherrie; Wing, Claudia; Jiang, Chen; Kelly, William Kevin; Patel, Jai; Halabi, Susan; Furukawa, Yoichi; Wheeler, Heather E; Sibley, Alexander B; Lassiter, Cameron; Weisman, Lois; Watson, Dorothy; Krens, Stefanie D; Mulkey, Flora; Renn, Cynthia L; Small, Eric J; Febbo, Phillip G; Shterev, Ivo; Kroetz, Deanna L; Friedman, Paula N; Mahoney, John F; Carducci, Michael A; Kelley, Michael J; Nakamura, Yusuke; Kubo, Michiaki; Dorsey, Susan G; Dolan, M Eileen; Morris, Michael J; Ratain, Mark J; McLeod, Howard L.
Afiliação
  • Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan. UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Owzar K; Duke Cancer Institute, Durham, North Carolina. Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Lessans S; Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland.
  • Wing C; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Jiang C; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Kelly WK; Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Patel J; UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
  • Halabi S; Duke Cancer Institute, Durham, North Carolina. Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Furukawa Y; Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Wheeler HE; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Sibley AB; Duke Cancer Institute, Durham, North Carolina.
  • Lassiter C; Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland.
  • Weisman L; Life Sciences Institute, University of Michigan, Ann Arbor, Michigan.
  • Watson D; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Krens SD; UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht, the Netherlands.
  • Mulkey F; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Renn CL; Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland.
  • Small EJ; Department of Medicine, UCSF, San Francisco, California.
  • Febbo PG; Genomic Health, Redwood City, California.
  • Shterev I; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Kroetz DL; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.
  • Friedman PN; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Mahoney JF; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.
  • Carducci MA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.
  • Kelley MJ; Durham VA Medical Center, Duke University Medical Center, Durham, North Carolina.
  • Nakamura Y; Department of Medicine, University of Chicago, Chicago, Illinois. Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kubo M; Lab for Genotyping Development, Riken Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Dorsey SG; Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, Maryland.
  • Dolan ME; Department of Medicine, University of Chicago, Chicago, Illinois.
  • Morris MJ; Memorial Sloan Kettering Cancer Center, New York.
  • Ratain MJ; Department of Medicine, University of Chicago, Chicago, Illinois.
  • McLeod HL; UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida. Howard.mcleod@moffitt.org.
Clin Cancer Res ; 22(19): 4890-4900, 2016 Oct 01.
Article em En | MEDLINE | ID: mdl-27143689
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polineuropatias / Protocolos de Quimioterapia Combinada Antineoplásica / Predisposição Genética para Doença / Taxoides / Neoplasias de Próstata Resistentes à Castração / Proteínas de Membrana Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Animals / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polineuropatias / Protocolos de Quimioterapia Combinada Antineoplásica / Predisposição Genética para Doença / Taxoides / Neoplasias de Próstata Resistentes à Castração / Proteínas de Membrana Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Animals / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Ano de publicação: 2016 Tipo de documento: Article